Altre lingue Senseonics Holdings, Inc.

Azioni

SENS

US81727U1051

Mercato chiuso - Nyse Altri mercati azionari 22:00:00 05/07/2024			Variaz. 5gg	Var. 1 gen.
0,3922 ^USD	+0,28%		-1,70%	-31,21%

23/06	Transcript : Senseonics Holdings, Inc. - Shareholder/Analyst Call
21/06	Senseonics prevede per il 2024 un fatturato netto compreso tra 22 e 24 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook	24/06
Senseonics Expects 2024 Net Revenue $22 Million to $24 Million	21/06
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook	21/06
Senseonics Holdings, Inc. Reaffirms Revenue Guidance for the First Half and Provides Revenue Guidance for the Full Year of 2024	21/06
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions	13/06
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference	29/05
Senseonics: Q1 Earnings Snapshot	13/05
Senseonics Holdings, Inc. Provides Earnings Guidance for the First Half 2024	13/05
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q1 Revenue $5.1M, vs. Street Est of $4.6M	13/05
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results	13/05
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management	13/05
Senseonics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Senseonics Holdings, Inc. and Mercy Collaborate to Improve Diabetes Population Health Management	13/05
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution	09/05
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution	09/05
Senseonics Holdings, Inc. to Participate in Upcoming Conferences	02/05
Senseonics Holdings, Inc. - Eversense CGM System Receives iCGM Designation by the US FDA	01/05
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time	30/04
Eversense® CGM System Receives iCGM Designation by the US FDA	30/04
Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration	30/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Senseonics Holdings, Inc.

Azioni

SENS

US81727U1051

Altre lingue

Filtri